Quan Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Quan Zhang has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
Xiaoming Li
Department of Health Promotion, Education and Behavior, South Carolina SmartState Center for Healthcare Quality (CHQ), Arnold School of Public Health, University of South Carolina, Columbia, SC, USA
12 shared publicationsShan Qiao
Department of Health Promotion, Education and Behavior, South Carolina SmartState Center for Healthcare Quality (CHQ), Arnold School of Public Health, University of South Carolina, Columbia, SC, USA
11 shared publicationsYuejiao Zhou
Unit of AIDS Prevention and Control, Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Nanning, People’s Republic of China
9 shared publicationsZhiyong Shen
Department of HIV/STD Prevention, Guangxi Center for Disease Control and Prevention, Nanning, China
7 shared publications- Huihua Deng
Institute of Child Development and Education, Southeast University, China
6 shared publications - James A. Carson
Texas A&M University
6 shared publications
Latest Publications
- 1 October 2026
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 331 (4) , C1109-C1127
5-Fluorouracil-based chemotherapy disrupts autophagy flux and protein synthesis in cultured myotubes: a role for mTORC1 signaling
FOLFOX chemotherapy is a common treatment for colorectal cancer, consisting of a combination of the antimetabolite 5-FU, leucovorin, and oxaliplatin. The disruption of muscle cellular signaling caused by 5-FU-based chemotherapies, which leads to fatigue and weakness, remains poorly understood. Our results provide evidence that FOLFOX can directly suppress myotube AMPK signaling, protein synthesis, and autophagy flux. Importantly, the effects of FOLFOX and the resulting disruptions to muscle protein turnover are long-lasting and are not easily reversible.
- 1 October 2026
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 331 (4) , C1109-C1127
5-Fluorouracil-based chemotherapy disrupts autophagy flux and protein synthesis in cultured myotubes: a role for mTORC1 signaling
FOLFOX chemotherapy is a common treatment for colorectal cancer, consisting of a combination of the antimetabolite 5-FU, leucovorin, and oxaliplatin. The disruption of muscle cellular signaling caused by 5-FU-based chemotherapies, which leads to fatigue and weakness, remains poorly understood. Our results provide evidence that FOLFOX can directly suppress myotube AMPK signaling, protein synthesis, and autophagy flux. Importantly, the effects of FOLFOX and the resulting disruptions to muscle protein turnover are long-lasting and are not easily reversible.
- 1 January 2026
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 330 (1) , C166-C183
Sex impacts inflammatory signaling, body composition, and physical function in tumor-bearing mice receiving chemotherapy
The present study demonstrates that in colon tumor-bearing mice, the administration of FOLFOX chemotherapy alters plasma inflammatory cytokines’ relationship to tumor mass, body composition, and physical function. Furthermore, sex influences these responses. These findings have implications for mechanistically understanding sex-specific muscle wasting and metabolic complications experienced by patients with colorectal cancer undergoing chemotherapy treatment.
- 1 January 2026
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 330 (1) , C166-C183
Sex impacts inflammatory signaling, body composition, and physical function in tumor-bearing mice receiving chemotherapy
The present study demonstrates that in colon tumor-bearing mice, the administration of FOLFOX chemotherapy alters plasma inflammatory cytokines’ relationship to tumor mass, body composition, and physical function. Furthermore, sex influences these responses. These findings have implications for mechanistically understanding sex-specific muscle wasting and metabolic complications experienced by patients with colorectal cancer undergoing chemotherapy treatment.
- Open Access
- 1 December 2025
- Published by KEAI Publishing in Sports Medicine and Health Science
- Vol. 8 (5) , 509-523
The relationship between circulating osteocalcin and muscle mass measurements in humans: A systematic review and meta-analysis
- 1 December 2025
- Published by KEAI Publishing in Sports Medicine and Health Science
- Vol. 8 (5) , 509-523
Open AccessThe relationship between circulating osteocalcin and muscle mass measurements in humans: A systematic review and meta-analysis
- Open Access
- 10 September 2025
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 16 (5) , e70064
The Effect of Cachexia on the Feeding Regulation of Skeletal Muscle Protein Synthesis in Tumour‐Bearing Mice
Background: Cancer promotes muscle wasting through an imbalance in the tightly regulated protein synthesis and degradation processes. An array of intracellular signalling pathways, including mTORC1 and AMPK, regulate protein synthesis, and these pathways are responsive to the muscle's microenvironment and systemic stimuli. Although feeding and fasting are established systemic regulators of muscle mTORC1 and protein synthesis, the cancer environment's impact on these responses during cachexia development is poorly understood. Although the IL‐6 cytokine family has been widely investigated as a driver of cachexia with several cancers, how this signalling regulates muscle responses to feeding and fasting requires further study. We investigated if the cancer environment alters the feeding and fasting regulation of skeletal muscle protein synthesis and if the IL‐6 family of cytokines signalling through muscle glycoprotein 130 could regulate this response. Methods: Male C57BL/6J mice were subcutaneously injected with 1 × 10 6 LLC cells or PBS. Mice were euthanized 25–30 days post‐injection after a 12‐h dark cycle fast, followed by access to food pellets for 1 h (fed) or immediately sacrificed. To determine AMPK and gp13's regulation of protein synthesis and anabolic signalling, we injected tamoxifen‐inducible skeletal muscle AMPKa 1 a 2 or gp130 knockout and floxed control mice with LLC cells or PBS. The gastrocnemius muscle was analysed for protein expression. Results: Feeding increased p‐rpS6 and protein synthesis in PBS (2.2‐ and 0.4‐fold, p < 0.001) and LLC mice (1.7‐ and 0.9‐fold, p < 0.001), but overall, LLC significantly reduced p‐rpS6 and protein synthesis. Feeding only increased p‐AKT in PBS mice (1.5‐fold, p < 0.001). In vitro LLC‐conditioned media did not inhibit the insulin induction of myotube p‐AKT ( p < 0.001) and p‐rpS6 ( p < 0.001). Muscle gp130 loss reduced the fasting p‐AMPK induction in LLC mice but did not alter suppression of p‐AKT and p‐rpS6 and protein synthesis. Muscle AMPK loss increased p‐rpS6 (2.1‐fold, p < 0.001) and protein synthesis (0.7‐fold, p < 0.001) in PBS mice but did not restore LLC‐suppressed protein synthesis. Conclusions: Our study provides novel insight into muscle responsiveness to feeding and fasting in a cancer environment. We find the acute anabolic response to feeding is maintained during LLC‐induced cachexia, whereas the fasting catabolic response is exacerbated. Muscle‐specific gp130 loss prevented disrupted fasting AMPK activation but not protein synthesis. There is a need to understand the aberrant upstream and downstream regulation of muscle AMPK activity that is disrupted with cancer and leads to aberrant protein turnover regulation.
- 10 September 2025
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 16 (5) , e70064
Open AccessThe Effect of Cachexia on the Feeding Regulation of Skeletal Muscle Protein Synthesis in Tumour‐Bearing Mice
Background: Cancer promotes muscle wasting through an imbalance in the tightly regulated protein synthesis and degradation processes. An array of intracellular signalling pathways, including mTORC1 and AMPK, regulate protein synthesis, and these pathways are responsive to the muscle's microenvironment and systemic stimuli. Although feeding and fasting are established systemic regulators of muscle mTORC1 and protein synthesis, the cancer environment's impact on these responses during cachexia development is poorly understood. Although the IL‐6 cytokine family has been widely investigated as a driver of cachexia with several cancers, how this signalling regulates muscle responses to feeding and fasting requires further study. We investigated if the cancer environment alters the feeding and fasting regulation of skeletal muscle protein synthesis and if the IL‐6 family of cytokines signalling through muscle glycoprotein 130 could regulate this response. Methods: Male C57BL/6J mice were subcutaneously injected with 1 × 10 6 LLC cells or PBS. Mice were euthanized 25–30 days post‐injection after a 12‐h dark cycle fast, followed by access to food pellets for 1 h (fed) or immediately sacrificed. To determine AMPK and gp13's regulation of protein synthesis and anabolic signalling, we injected tamoxifen‐inducible skeletal muscle AMPKa 1 a 2 or gp130 knockout and floxed control mice with LLC cells or PBS. The gastrocnemius muscle was analysed for protein expression. Results: Feeding increased p‐rpS6 and protein synthesis in PBS (2.2‐ and 0.4‐fold, p < 0.001) and LLC mice (1.7‐ and 0.9‐fold, p < 0.001), but overall, LLC significantly reduced p‐rpS6 and protein synthesis. Feeding only increased p‐AKT in PBS mice (1.5‐fold, p < 0.001). In vitro LLC‐conditioned media did not inhibit the insulin induction of myotube p‐AKT ( p < 0.001) and p‐rpS6 ( p < 0.001). Muscle gp130 loss reduced the fasting p‐AMPK induction in LLC mice but did not alter suppression of p‐AKT and p‐rpS6 and protein synthesis. Muscle AMPK loss increased p‐rpS6 (2.1‐fold, p < 0.001) and protein synthesis (0.7‐fold, p < 0.001) in PBS mice but did not restore LLC‐suppressed protein synthesis. Conclusions: Our study provides novel insight into muscle responsiveness to feeding and fasting in a cancer environment. We find the acute anabolic response to feeding is maintained during LLC‐induced cachexia, whereas the fasting catabolic response is exacerbated. Muscle‐specific gp130 loss prevented disrupted fasting AMPK activation but not protein synthesis. There is a need to understand the aberrant upstream and downstream regulation of muscle AMPK activity that is disrupted with cancer and leads to aberrant protein turnover regulation.
- 1 July 2024
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 327 (1) , C124-C139
mTORC1 and BMP-Smad1/5 regulation of serum-stimulated myotube hypertrophy: a role for autophagy
The present study demonstrates that myotube hypertrophy caused by chronic serum stimulation requires mammalian target of rapamycin complex 1 (mTORC1) signaling but not bone morphogenetic protein (BMP)-Smad1/5 signaling. The suppression of autophagy flux was associated with serum-induced myotube hypertrophy and mTORC1 regulation of autophagy flux by measuring LC3BII/I expression. Rapamycin is widely investigated for beneficial effects in aging skeletal muscle and sarcopenia; our results provide evidence that rapamycin can regulate autophagy-related signaling during myotube growth, which could benefit skeletal muscle functional and metabolic health.
- 1 July 2024
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 327 (1) , C124-C139
mTORC1 and BMP-Smad1/5 regulation of serum-stimulated myotube hypertrophy: a role for autophagy
The present study demonstrates that myotube hypertrophy caused by chronic serum stimulation requires mammalian target of rapamycin complex 1 (mTORC1) signaling but not bone morphogenetic protein (BMP)-Smad1/5 signaling. The suppression of autophagy flux was associated with serum-induced myotube hypertrophy and mTORC1 regulation of autophagy flux by measuring LC3BII/I expression. Rapamycin is widely investigated for beneficial effects in aging skeletal muscle and sarcopenia; our results provide evidence that rapamycin can regulate autophagy-related signaling during myotube growth, which could benefit skeletal muscle functional and metabolic health.
- Open Access
- 3 August 2022
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 16, 1885-1896
Hair Zidovudine Concentrations Predict Virologic Outcomes Among People Living with HIV/AIDS in China
Background: Hair antiretroviral concentrations are an objective and non-invasive measure of adherence to long-term antiretroviral therapy (ART) and can further predict virologic outcomes among people living with HIV/AIDS (PLWH). Zidovudine, one of the mainstream antiretrovirals in China, has been verified to have high reliability in adherence assessment, especially for its hair concentrations. However, data are limited in its predicting virologic outcomes. Therefore, this study aimed to characterize whether hair zidovudine concentrations can predict virologic suppression among Chinese PLWH compared with hair lamivudine concentrations and two self-reported measures, the overall frequency of adherence behaviors and percentage adherence. Methods: This cross-sectional study randomly recruited 564 PLWH currently treated with zidovudine, lamivudine, and other ART agents (efavirenz, nevirapine, or lopinavir/ritonavir) in Guangxi, China. Hair antiretroviral concentrations were determined using the LC-ESI+-MS/MS method. Receiver operating characteristic (ROC) curves were used to estimate the optimal classification thresholds of hair concentrations of zidovudine and lamivudine, and the two self-reported measures. Based on those optimal classification thresholds, logistic regression was used to examine whether those four adherence measures can predict virologic suppression (HIV-1 RNA < 200 copies/mL). Results: ROC curves demonstrated good classification performance for association with virologic suppression of zidovudine with the optimal threshold at 58 pg/mg and lamivudine at 255 pg/mg but no self-reported measures. PLWH with hair zidovudine concentrations > 58 pg/mg had an adjusted odds ratio (aOR) of 43.191 (95% confidence interval (CI) = 10.171‒183.418, p < 0.001) for virologic suppression. Hair lamivudine concentrations were also associated with virologic suppression (aOR = 10.656, 95% CI = 3.670‒30.943, p < 0.001). However, two self-reported measures did not predict virologic suppression (aORs = 1.157 and 2.488, ps > 0.149). Conclusion: Hair zidovudine concentrations can be served as an alternative tool for clinically predicting virologic suppression among PLWH in China.
- 3 August 2022
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 16, 1885-1896
Open AccessHair Zidovudine Concentrations Predict Virologic Outcomes Among People Living with HIV/AIDS in China
Background: Hair antiretroviral concentrations are an objective and non-invasive measure of adherence to long-term antiretroviral therapy (ART) and can further predict virologic outcomes among people living with HIV/AIDS (PLWH). Zidovudine, one of the mainstream antiretrovirals in China, has been verified to have high reliability in adherence assessment, especially for its hair concentrations. However, data are limited in its predicting virologic outcomes. Therefore, this study aimed to characterize whether hair zidovudine concentrations can predict virologic suppression among Chinese PLWH compared with hair lamivudine concentrations and two self-reported measures, the overall frequency of adherence behaviors and percentage adherence. Methods: This cross-sectional study randomly recruited 564 PLWH currently treated with zidovudine, lamivudine, and other ART agents (efavirenz, nevirapine, or lopinavir/ritonavir) in Guangxi, China. Hair antiretroviral concentrations were determined using the LC-ESI+-MS/MS method. Receiver operating characteristic (ROC) curves were used to estimate the optimal classification thresholds of hair concentrations of zidovudine and lamivudine, and the two self-reported measures. Based on those optimal classification thresholds, logistic regression was used to examine whether those four adherence measures can predict virologic suppression (HIV-1 RNA < 200 copies/mL). Results: ROC curves demonstrated good classification performance for association with virologic suppression of zidovudine with the optimal threshold at 58 pg/mg and lamivudine at 255 pg/mg but no self-reported measures. PLWH with hair zidovudine concentrations > 58 pg/mg had an adjusted odds ratio (aOR) of 43.191 (95% confidence interval (CI) = 10.171‒183.418, p < 0.001) for virologic suppression. Hair lamivudine concentrations were also associated with virologic suppression (aOR = 10.656, 95% CI = 3.670‒30.943, p < 0.001). However, two self-reported measures did not predict virologic suppression (aORs = 1.157 and 2.488, ps > 0.149). Conclusion: Hair zidovudine concentrations can be served as an alternative tool for clinically predicting virologic suppression among PLWH in China.
- 11 July 2022
- Published by Wiley in The FASEB Journal
- Vol. 36 (8) , e22437
Short duration treadmill exercise improves physical function and skeletal muscle mitochondria protein expression after recovery from FOLFOX chemotherapy in male mice
FOLFOX (5‐FU, leucovorin, oxaliplatin) is a chemotherapy treatment for colorectal cancer which induces toxic side effects involving fatigue, weakness, and skeletal muscle dysfunction. There is a limited understanding of the recovery from these toxicities after treatment cessation. Exercise training can improve chemotherapy‐related toxicities. However, how exercise accelerates recovery and the dose required for these benefits are not well examined. The purpose of this study was to examine the effect of exercise duration on physical function, muscle mass, and mitochondria protein expression during the recovery from FOLFOX chemotherapy. 12‐week‐old male mice were administered four cycles of either PBS or FOLFOX over 8‐weeks. Outcomes were assessed after the fourth cycle and after either 4 (short‐term; STR) or 10 weeks (long‐term; LTR) recovery. Subsets of mice performed 14 sessions (6 d/wk, 18 m/min, 5% grade) of 60 min/d (long) or 15 min/d (short duration) treadmill exercise during STR. Red and white gastrocnemius mRNA and protein expression were examined. FOLFOX treatment decreased run time (RT) (−53%) and grip strength (GS) (−9%) compared to PBS. FOLFOX also reduced muscle OXPHOS complexes, COXIV, and VDAC protein expression. At LTR, FOLFOX RT (−36%) and GS (−16%) remained reduced. Long‐ and short‐duration treadmill exercise improved RT (+58% and +56%) without restoring GS in FOLFOX mice. Both exercise durations increased muscle VDAC and COXIV expression in FOLFOX mice. These data provide evidence that FOLFOX chemotherapy induces persistent deficits in physical function that can be partially reversed by short‐duration aerobic exercise.
- 11 July 2022
- Published by Wiley in The FASEB Journal
- Vol. 36 (8) , e22437
Short duration treadmill exercise improves physical function and skeletal muscle mitochondria protein expression after recovery from FOLFOX chemotherapy in male mice
FOLFOX (5‐FU, leucovorin, oxaliplatin) is a chemotherapy treatment for colorectal cancer which induces toxic side effects involving fatigue, weakness, and skeletal muscle dysfunction. There is a limited understanding of the recovery from these toxicities after treatment cessation. Exercise training can improve chemotherapy‐related toxicities. However, how exercise accelerates recovery and the dose required for these benefits are not well examined. The purpose of this study was to examine the effect of exercise duration on physical function, muscle mass, and mitochondria protein expression during the recovery from FOLFOX chemotherapy. 12‐week‐old male mice were administered four cycles of either PBS or FOLFOX over 8‐weeks. Outcomes were assessed after the fourth cycle and after either 4 (short‐term; STR) or 10 weeks (long‐term; LTR) recovery. Subsets of mice performed 14 sessions (6 d/wk, 18 m/min, 5% grade) of 60 min/d (long) or 15 min/d (short duration) treadmill exercise during STR. Red and white gastrocnemius mRNA and protein expression were examined. FOLFOX treatment decreased run time (RT) (−53%) and grip strength (GS) (−9%) compared to PBS. FOLFOX also reduced muscle OXPHOS complexes, COXIV, and VDAC protein expression. At LTR, FOLFOX RT (−36%) and GS (−16%) remained reduced. Long‐ and short‐duration treadmill exercise improved RT (+58% and +56%) without restoring GS in FOLFOX mice. Both exercise durations increased muscle VDAC and COXIV expression in FOLFOX mice. These data provide evidence that FOLFOX chemotherapy induces persistent deficits in physical function that can be partially reversed by short‐duration aerobic exercise.
- Open Access
- 20 March 2022
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 22 (1) , 1-8
The relationship of hair glucocorticoid levels to immunological and virological outcomes in a large cohort of combination antiretroviral therapy treated people living with HIV
Background: Existing literature mostly investigated the relationship of acute or short-term glucocorticoid exposure to HIV disease progression using cortisol levels in serum, saliva, or urine. Data are limited on the relationship of long-term glucocorticoid exposure to HIV disease progression. This study examined whether hair glucocorticoid levels, novel retrospective indicators of long-term glucocorticoid exposure, are associated with two common indicators of HIV disease progression (CD4 count and HIV viral load) among a large cohort of combination antiretroviral therapy treated Chinese people living with HIV (PLHIV). Methods: A total of 1198 treated PLHIV provided hair samples for glucocorticoid (cortisol and cortisone) assay and completed a survey assessing sociodemographic, lifestyle, and HIV-related characteristics. Meanwhile, CD4 count and HIV viral load were retrieved from their medical records. Spearman correlation was used to examine the associations of hair cortisol and cortisone levels to continuous CD4 count and HIV viral load. Multivariate logistic regression was used to predict CD4 count < 500 cells/mm3. Results: Both hair cortisol and cortisone levels were negatively associated with CD4 count but not with HIV viral load. The odds ratio for CD4 count < 500 cells/mm3 was 1.41 [95% CI 0.99–2.00] and 2.15 [95% CI 1.51–3.05] for those with hair cortisol and cortisone levels in the highest quartile compared to the lowest when controlling for sociodemographic, lifestyle, HIV-related covariates, and HIV viral load. Conclusion: Hair glucocorticoid levels were associated with CD4 count but not viral load in treated Chinese PLHIV. Our data furtherly supported the hypothesis that elevated glucocorticoid levels are associated with the lower CD4 count.
- 20 March 2022
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 22 (1) , 1-8
Open AccessThe relationship of hair glucocorticoid levels to immunological and virological outcomes in a large cohort of combination antiretroviral therapy treated people living with HIV
Background: Existing literature mostly investigated the relationship of acute or short-term glucocorticoid exposure to HIV disease progression using cortisol levels in serum, saliva, or urine. Data are limited on the relationship of long-term glucocorticoid exposure to HIV disease progression. This study examined whether hair glucocorticoid levels, novel retrospective indicators of long-term glucocorticoid exposure, are associated with two common indicators of HIV disease progression (CD4 count and HIV viral load) among a large cohort of combination antiretroviral therapy treated Chinese people living with HIV (PLHIV). Methods: A total of 1198 treated PLHIV provided hair samples for glucocorticoid (cortisol and cortisone) assay and completed a survey assessing sociodemographic, lifestyle, and HIV-related characteristics. Meanwhile, CD4 count and HIV viral load were retrieved from their medical records. Spearman correlation was used to examine the associations of hair cortisol and cortisone levels to continuous CD4 count and HIV viral load. Multivariate logistic regression was used to predict CD4 count < 500 cells/mm3. Results: Both hair cortisol and cortisone levels were negatively associated with CD4 count but not with HIV viral load. The odds ratio for CD4 count < 500 cells/mm3 was 1.41 [95% CI 0.99–2.00] and 2.15 [95% CI 1.51–3.05] for those with hair cortisol and cortisone levels in the highest quartile compared to the lowest when controlling for sociodemographic, lifestyle, HIV-related covariates, and HIV viral load. Conclusion: Hair glucocorticoid levels were associated with CD4 count but not viral load in treated Chinese PLHIV. Our data furtherly supported the hypothesis that elevated glucocorticoid levels are associated with the lower CD4 count.
- 15 February 2022
- Published by Taylor & Francis in Autoimmunity
- Vol. 55 (4) , 264-274
Circ_0016347 modulates proliferation, migration, invasion, cell cycle, and apoptosis of osteosarcoma cells via the miR-661/IL6R axis
Osteosarcoma is a common primary bone tumour in children and adolescents. Circular RNAs (circRNAs) exert vital functions in human diseases, including osteosarcoma. Therefore, we explored the role of circ_0016347 in osteosarcoma. The real-time quantitative polymerase chain reaction (RT-qPCR) was used to detect the expression levels of circ_0016347, microRNA-661 (miR-661), and Interleukin-6 receptor (IL6R) in osteosarcoma tissues and cells. The proliferation of osteosarcoma cells was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazol-3-ium bromide (MTT) and EdU experiments. The migration and invasion were determined by transwell assay. The cell cycle distribution and apoptosis were assessed by flow cytometry assay. The association relationships among circ_0016347, miR-661, and IL6R were analyzed by dual-luciferase reporter assays. The western blot assay was employed to assay the protein expression. A xenograft experiment was established to clarify the functional role of circ_0016347 inhibition in vivo. Circ_0016347 was obviously overexpressed in osteosarcoma tissues and cells compared with control groups. The suppression of circ_0016347 impeded proliferation, migration, invasion, and cell cycle and induced apoptosis in osteosarcoma cells, which was overturned by knockdown of miR-661. Consistently, circ_0016347 knockdown repressed tumour growth in vivo. Moreover, miR-661 directly targeted and inhibited IL6R, and the upregulation of IL6R reversed miR-661-induced effects on osteosarcoma cells. Furthermore, circ_0016347 could regulate IL6R expression through miR-661. Inhibition of circ_0016347 also inactivated the Janus kinase 2 (JAK2)/Transcription 3 (STAT3) signalling pathway in osteosarcoma cells by IL6R. Circ_0016347 functioned as an oncogene in osteosarcoma at least in part by the miR-661/IL6R axis and JAK2/STAT3 signalling pathway.
- 15 February 2022
- Published by Taylor & Francis in Autoimmunity
- Vol. 55 (4) , 264-274
Circ_0016347 modulates proliferation, migration, invasion, cell cycle, and apoptosis of osteosarcoma cells via the miR-661/IL6R axis
Osteosarcoma is a common primary bone tumour in children and adolescents. Circular RNAs (circRNAs) exert vital functions in human diseases, including osteosarcoma. Therefore, we explored the role of circ_0016347 in osteosarcoma. The real-time quantitative polymerase chain reaction (RT-qPCR) was used to detect the expression levels of circ_0016347, microRNA-661 (miR-661), and Interleukin-6 receptor (IL6R) in osteosarcoma tissues and cells. The proliferation of osteosarcoma cells was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazol-3-ium bromide (MTT) and EdU experiments. The migration and invasion were determined by transwell assay. The cell cycle distribution and apoptosis were assessed by flow cytometry assay. The association relationships among circ_0016347, miR-661, and IL6R were analyzed by dual-luciferase reporter assays. The western blot assay was employed to assay the protein expression. A xenograft experiment was established to clarify the functional role of circ_0016347 inhibition in vivo. Circ_0016347 was obviously overexpressed in osteosarcoma tissues and cells compared with control groups. The suppression of circ_0016347 impeded proliferation, migration, invasion, and cell cycle and induced apoptosis in osteosarcoma cells, which was overturned by knockdown of miR-661. Consistently, circ_0016347 knockdown repressed tumour growth in vivo. Moreover, miR-661 directly targeted and inhibited IL6R, and the upregulation of IL6R reversed miR-661-induced effects on osteosarcoma cells. Furthermore, circ_0016347 could regulate IL6R expression through miR-661. Inhibition of circ_0016347 also inactivated the Janus kinase 2 (JAK2)/Transcription 3 (STAT3) signalling pathway in osteosarcoma cells by IL6R. Circ_0016347 functioned as an oncogene in osteosarcoma at least in part by the miR-661/IL6R axis and JAK2/STAT3 signalling pathway.
- 27 September 2021
- Published by Taylor & Francis in Psychology, Health & Medicine
- Vol. 27 (4) , 937-947
Stress coping strategies and their perceived effectiveness among HIV/AIDS healthcare providers in China: a qualitative study
Previous studies have suggested that many HIV/AIDS healthcare providers (HCPs), especially those in resource-poor settings, suffer from various work-related stress because of the complexity of HIV/AIDS patients’ medical conditions, occupational exposure, HIV-related stigma, and challenges with patients’ physical, mental, and social conditions. However, data are limited regarding how HIV/AIDS HCPs cope with the stress and their perceived effectiveness of these coping strategies. This qualitative study was designed to explore HCPs’ coping strategies and their perceptions of effectiveness of these strategies. We conducted in-depth face-to-face interviews with 46 HIV/AIDS HCPs in Guangxi, China. The interviews were audio-recorded, transcribed and imported into NVivo V.11. Data were analyzed using a thematic approach. The analysis of the data revealed six general coping strategies: seeking social support, applying problem-solving strategies, adopting healthy lifestyle, developing self-compassion, using mindfulness-based stress reduction methods, and avoidance and escaping. It is imperative to increase institutional support and develop training programs to improve problem-solving skills, healthy lifestyle, and self-compassion among HIV/AIDS HCPs in China.
- 27 September 2021
- Published by Taylor & Francis in Psychology, Health & Medicine
- Vol. 27 (4) , 937-947
Stress coping strategies and their perceived effectiveness among HIV/AIDS healthcare providers in China: a qualitative study
Previous studies have suggested that many HIV/AIDS healthcare providers (HCPs), especially those in resource-poor settings, suffer from various work-related stress because of the complexity of HIV/AIDS patients’ medical conditions, occupational exposure, HIV-related stigma, and challenges with patients’ physical, mental, and social conditions. However, data are limited regarding how HIV/AIDS HCPs cope with the stress and their perceived effectiveness of these coping strategies. This qualitative study was designed to explore HCPs’ coping strategies and their perceptions of effectiveness of these strategies. We conducted in-depth face-to-face interviews with 46 HIV/AIDS HCPs in Guangxi, China. The interviews were audio-recorded, transcribed and imported into NVivo V.11. Data were analyzed using a thematic approach. The analysis of the data revealed six general coping strategies: seeking social support, applying problem-solving strategies, adopting healthy lifestyle, developing self-compassion, using mindfulness-based stress reduction methods, and avoidance and escaping. It is imperative to increase institutional support and develop training programs to improve problem-solving skills, healthy lifestyle, and self-compassion among HIV/AIDS HCPs in China.